Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines
- PMID: 11235992
- DOI: 10.1023/a:1006778000173
Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines
Abstract
The ability of a cell to modify the extracellular matrix is important in several pathophysiological alterations including tumorigenesis. Cell transformation is accompanied by changes in the surrounding stroma as a result of the action of specific proteases such as the urokinase plasminogen activator (uPA), which has been associated with invasive potential in many tumor types. In this study, we analyzed the release of vesicle-associated uPA by the aggressive prostatic carcinoma cell line PC3 and the implications of this release for the invasive behaviour of prostatic tumor cells. Zymography and Western blot analysis revealed the presence of vesicle-associated uPA in the high-molecular weight form. Vesicles adhered to and degraded both collagen IV and reconstituted basal membrane (Matrigel), and plasminogen enhanced the degradation in a dose-dependent manner. Addition of membrane vesicles shed by PC3 cells to cultures of the poorly invasive prostate cancer cell line LnCaP enhanced the adhesive and invasive capabilities of the latter, suggesting a mechanism involving substrate recognition and degradation. Together, these findings indicate that membrane vesicles can promote tumor invasion and point to the important role of vesicle-associated uPA in the extracellular compartment.
Similar articles
-
Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.Clin Exp Metastasis. 1998 Aug;16(6):513-28. doi: 10.1023/a:1006590217724. Clin Exp Metastasis. 1998. PMID: 9872599
-
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells.Int J Cancer. 2000 Feb 1;85(3):407-15. Int J Cancer. 2000. PMID: 10652434
-
Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and matrigel invasion.Oncol Res. 1999;11(1):17-31. Oncol Res. 1999. PMID: 10451028
-
Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model.J Neurooncol. 1994;18(2):129-38. doi: 10.1007/BF01050419. J Neurooncol. 1994. PMID: 7964975 Review.
-
Tumor-associated urokinase-type plasminogen activator: biological and clinical significance.Biol Chem Hoppe Seyler. 1992 Jul;373(7):611-22. doi: 10.1515/bchm3.1992.373.2.611. Biol Chem Hoppe Seyler. 1992. PMID: 1515091 Review.
Cited by
-
Voltage gated sodium channels in cancer and their potential mechanisms of action.Channels (Austin). 2019 Dec;13(1):400-409. doi: 10.1080/19336950.2019.1666455. Channels (Austin). 2019. PMID: 31510893 Free PMC article.
-
Extracellular vesicles in prostate cancer: new future clinical strategies?Biomed Res Int. 2014;2014:561571. doi: 10.1155/2014/561571. Epub 2014 Feb 23. Biomed Res Int. 2014. PMID: 24707491 Free PMC article. Review.
-
Physiopathology of spine metastasis.Int J Surg Oncol. 2011;2011:107969. doi: 10.1155/2011/107969. Epub 2011 Aug 10. Int J Surg Oncol. 2011. PMID: 22312491 Free PMC article.
-
Elastin-derived peptides increase invasive capacities of lung cancer cells by post-transcriptional regulation of MMP-2 and uPA.Clin Exp Metastasis. 2012 Jun;29(5):511-22. doi: 10.1007/s10585-012-9467-3. Epub 2012 Mar 21. Clin Exp Metastasis. 2012. PMID: 22434583
-
Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers.Genes Dev. 2012 Jun 15;26(12):1287-99. doi: 10.1101/gad.192351.112. Genes Dev. 2012. PMID: 22713869 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous